Evgen Pharma PLC – AGM Statement
18th July 2019
Evgen Pharma (AIM: EVG), a clinical stage drug development company focused on the treatment of cancer and neurological conditions, will hold its Annual General Meeting ("AGM") later today. At the...
Read More